In our study, where we identified a risk of developing overweight and obesity in the BBS heterozygous carriers group, we also noted that the creatinine levels in the carriers' group were lower than those in the non-carriers' group, with significant differences observed. The gene discussed is BBS2; the disease is obesity due to melanocortin 4 receptor deficiency.